Y0001701

赖诺普利

European Pharmacopoeia (EP) Reference Standard

• 别名: 赖诺普利, MK-521, （S）-1- [N2-（1-羧基-3-苯丙基）-赖氨酰脯氨酸 二水合物
• 经验公式（希尔记法）: C₂₁H₃₁O₅N₃ · 2H₂O
• CAS号: 83915-83-7
• 分子量: 441.52
• MDL號碼: MFCD01698825
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329830790
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: lisinopril
• 製造商／商標名: EDQM
• 應用: pharmaceutical (small molecule)
• 形式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: [H]O[H].[H]O[H].NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O
• InChI: 1S/C21H31N3O5.2H2O/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15;;/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29);2*1H2/t16-,17-,18-;;/m0../s1
• InChI 密鑰: CZRQXSDBMCMPNJ-ZUIPZQNBSA-N
• 基因資訊: human ... ACE(1636)

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Lisinopril for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生化／生理作用

血管紧张素转换酶（ACE）抑制剂。

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS08
• 訊號詞: Danger
• 危險聲明: H360D,H373
• 防範說明: P202 - P260 - P280 - P308 + P313 - P405 - P501
• 危險分類: Repr. 1A - STOT RE 2
• 標靶器官: Kidney
• 儲存類別代碼: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable